[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fgu5ZB8BZ2jIhYSvuMv8KcSiKyQ2O6reKJVLSrhBiXWI":8,"$f0EmplI_M_t2-m1PkqfdCkqSwPGUDszuJ-kI5g258M3Y":55,"$fvhfC3OXfFnIF3Zz4ocGBfM77fXYP6lfWXFjh7BGk8CY":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},51452,867252,[],"https://ystcdn.venuertc.com/medical/ystApp/3PMFog9SJLbtP3VML2xGXUy2tMSMprgU.png","曾珊珊","潍坊市益都中心医院","血液内科","住院医师",447,0,"💊 对抗弥漫大B细胞淋巴瘤：关键药品安全用药全指南","","https://ystcdn.venuertc.com/venue/AI/750997c8-0efd-488b-8abf-2b8811c5ad6c.jpg","\u003Cdiv class=\"expert-content-wrapper\">\n\n  \u003C!-- 标题区 -->\n  \u003Ch1 id=\"material_title\" class=\"expert-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    💊 对抗弥漫大B细胞淋巴瘤：关键药品安全用药全指南\n  \u003C/h1>\n  \u003Cdiv class=\"expert-title-bg subtle-bg\">\u003C/div>\n  \u003Cp class=\"expert-intro\">\n    说到针对弥漫大B细胞淋巴瘤的治疗用药，不管是化疗、免疫还是靶向药物，大家最关心的还是怎么用、有哪些注意事项、怎么规避风险。其实，掌握个中细节，能让用药效果事半功倍，还能明显降低不良反应。本指南将围绕7个核心细节，帮你逐条理清每一类常见主要用药的正确用法和安全警示，让用药更安心。\n  \u003C/p>\n\n  \u003C!-- 1. 主要药物类别与作用机制 -->\n  \u003Ch2 class=\"expert-subtitle expert-bg-mechanism\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    01 主要药品分类与作用机制详解\n  \u003C/h2>\n  \u003Cdiv class=\"expert-subtitle-bg subtle-bg\">\u003C/div>\n  \u003Cdiv class=\"expert-section\">\n    \u003Cul class=\"expert-ul-list\">\n      \u003Cli>\n        \u003Cstrong>利妥昔单抗（Rituximab）\u003C/strong>：人鼠嵌合型抗CD20单克隆抗体，结合B细胞表面CD20抗原，通过激活补体和调动免疫细胞清除异常B细胞。\u003Cbr>\n        \u003Cspan class=\"expert-tip\">机制重点：主要针对B细胞，不影响T细胞。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺（Cyclophosphamide）\u003C/strong>：属于烷化剂，直接通过破坏肿瘤细胞DNA结构抑制细胞分裂。\u003Cbr>\n        \u003Cspan class=\"expert-tip\">机制重点：广谱，抑制快速分裂的细胞，包括淋巴球。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>阿霉素（多柔比星，Doxorubicin）\u003C/strong>：蒽环类抗生素，嵌入DNA，引发断裂并抑制DNA拓扑酶II活性，阻止细胞繁殖。\u003Cbr>\n        \u003Cspan class=\"expert-tip\">机制重点：阻断DNA/ RNA合成。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>长春新碱（Vincristine）\u003C/strong>：微管抑制剂，阻止细胞微管装配，导致有丝分裂终止。\u003Cbr>\n        \u003Cspan class=\"expert-tip\">机制重点：特异性作用于有丝分裂期细胞。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>泼尼松（Prednisone）\u003C/strong>：糖皮质激素，抑制免疫反应及炎症反应。\u003Cbr>\n        \u003Cspan class=\"expert-tip\">机制重点：改善症状、辅助杀伤肿瘤细胞。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>来那度胺（Lenalidomide）\u003C/strong>：免疫调节剂，增强免疫系统对肿瘤细胞的清除，同时抑制肿瘤血管生成。\u003Cbr>\n        \u003Cspan class=\"expert-tip\">机制重点：免疫激活+抗血管生成双重抑制。\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\n  \u003C!-- 2. 用药方案与正确服用方法 -->\n  \u003Ch2 class=\"expert-subtitle expert-bg-usage\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    02 用药方案及正确服用方法\n  \u003C/h2>\n  \u003Cdiv class=\"expert-subtitle-bg subtle-bg\">\u003C/div>\n  \u003Cdiv class=\"expert-section\">\n    \u003Cul class=\"expert-ul-list\">\n      \u003Cli>\n        \u003Cstrong>利妥昔单抗\u003C/strong>：\u003Cbr>\n        \u003Cspan class=\"expert-highlight\">给药途径：\u003C/span> 静脉输注。\u003Cbr>\n        \u003Cspan class=\"expert-highlight\">注意：\u003C/span> 初次输注前需慢速，严密监控过敏反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>CHOP方案 (环磷酰胺+阿霉素+长春新碱+泼尼松)\u003C/strong>：\u003Cbr>\n        \u003Cspan class=\"expert-highlight\">给药方式：\u003C/span> 前三种通过静脉注射，泼尼松需口服，早晨给药更易耐受。\u003Cbr>\n        \u003Cspan class=\"expert-highlight\">泼尼松\u003C/span> 通常清晨一次性服用，避免晚上影响睡眠。\u003Cbr>\n        \u003Cspan class=\"expert-tip\">服药期间应大量饮水，特别是环磷酰胺，帮助预防膀胱毒性。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>来那度胺\u003C/strong>：\u003Cbr>\n        \u003Cspan class=\"expert-highlight\">剂型：\u003C/span> 口服胶囊，每日一次，饭前或饭后均可。\u003Cbr>\n        \u003Cspan class=\"expert-highlight\">用药周期：\u003C/span> 通常21天服药后停药7天，依据医生方案调整。\u003Cbr>\n        \u003Cspan class=\"expert-tip\">服药务必整粒吞服，勿掰开或咬碎。\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"expert-info-box\">\n      🕗 \u003Cstrong>正确做法：\u003C/strong>\u003Cbr>\n      按医生指定的剂量与周期规律服用，切忌自行增减药量或随意停药。所有静脉注射药物必须在医疗专业人员指导下完成。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 3. 剂型差异与服药技巧 -->\n  \u003Ch2 class=\"expert-subtitle expert-bg-form\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    03 剂型特点与服药技巧\n  \u003C/h2>\n  \u003Cdiv class=\"expert-subtitle-bg subtle-bg\">\u003C/div>\n  \u003Cdiv class=\"expert-section\">\n    \u003Cul class=\"expert-ul-list\">\n      \u003Cli>\n        \u003Cstrong>口服剂型\u003C/strong>（如泼尼松、来那度胺）：必须整粒吞服，不可咬碎。部分药品（如来那度胺）服药时建议足量饮水辅助下咽。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>注射剂型\u003C/strong>（利妥昔单抗、CHOP成分注射药）：仅限医疗机构使用，绝不应自行注射。\u003Cbr>\n        \u003Cspan class=\"expert-tip\">个别药物需稀释至指定浓度，勿任意调换溶剂。\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"expert-info-box\">\n      💧\u003Cstrong>正确做法：\u003C/strong>服药时多饮水，特别是化疗期间，帮助减少药物对身体的刺激。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 4. 药物相互作用需注意的几个组合 -->\n  \u003Ch2 class=\"expert-subtitle expert-bg-interaction\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    04 药物相互作用：这些组合要规避\n  \u003C/h2>\n  \u003Cdiv class=\"expert-subtitle-bg subtle-bg\">\u003C/div>\n  \u003Cdiv class=\"expert-section\">\n    \u003Cul class=\"expert-ul-list\">\n      \u003Cli>\n        \u003Cstrong>利妥昔单抗\u003C/strong> 不建议与活疫苗共同使用，避免影响免疫反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺\u003C/strong>：与别嘌醇、阿司匹林等药物合用时，可能加重骨髓抑制。\u003Cbr>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>多柔比星\u003C/strong>：避免与其他心脏毒性药物（如曲妥珠单抗）同用，可能增加心脏受损风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>长春新碱\u003C/strong>：与伊曲康唑等CYP3A4抑制剂共用，可能提升神经毒性。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>来那度胺\u003C/strong>：与华法林等抗凝药共同使用时需密切监测凝血功能。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"expert-info-box\">\n      🛑 \u003Cstrong>特别提醒：\u003C/strong>如需合并用药，务必提前咨询医生或药师，勿自行加药或停药。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 5. 适应症与禁忌症专栏 -->\n  \u003Ch2 class=\"expert-subtitle expert-bg-indication\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    05 使用适应症与核心禁忌\n  \u003C/h2>\n  \u003Cdiv class=\"expert-subtitle-bg subtle-bg\">\u003C/div>\n  \u003Cdiv class=\"expert-section\">\n    \u003Cul class=\"expert-ul-list\">\n      \u003Cli>\n        \u003Cstrong>利妥昔单抗\u003C/strong>：仅限CD20阳性B细胞相关疾病治疗， \u003Cspan class=\"expert-em\">禁用于对鼠、兔蛋白过敏者\u003C/span>。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>阿霉素\u003C/strong>：禁用于有严重心脏损害或近期心肌梗死病史者。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺\u003C/strong>：对该药或其他烷化剂过敏者禁止使用，严重肝肾功能障碍者慎用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>长春新碱\u003C/strong>：存在重度神经疾病或近期神经毒性表现者不宜使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>来那度胺\u003C/strong>：孕妇、哺乳期禁用，有严重肾功能损害者需调整剂量或避免用药。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"expert-info-box\">\n      ⚠️ \u003Cstrong>正确做法：\u003C/strong>开药前，主动告知医生既往过敏史、心脏和肝肾问题，已怀孕或哺乳请提前说明。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 6. 不良反应与处理方法汇总 -->\n  \u003Ch2 class=\"expert-subtitle expert-bg-adverse\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    06 常见不良反应与应对措施\n  \u003C/h2>\n  \u003Cdiv class=\"expert-subtitle-bg subtle-bg\">\u003C/div>\n  \u003Cdiv class=\"expert-section\">\n    \u003Cul class=\"expert-ul-list\">\n      \u003Cli>\n        \u003Cstrong>利妥昔单抗\u003C/strong>：首次输注常出现发热、寒战等输注反应，偶有过敏性休克。\u003Cbr>\n        \u003Cspan class=\"expert-tip\">正确做法：首次输注前可预防性服用抗过敏药物，全程监控生命体征。\n        \u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>环磷酰胺、多柔比星\u003C/strong>：有骨髓抑制风险，临床研究表明，\u003Cspan class=\"expert-highlight\">白细胞降低发生率可达30%-50%\u003C/span>\n        \u003Csup>\u003Ca href=\"#ref1\">[1]\u003C/a>\u003C/sup>，还可出现恶心、脱发等。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>长春新碱\u003C/strong>：常见周围神经病变（如手脚麻木），遇严重症状应及时报告医生。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>来那度胺\u003C/strong>：易引发血液系统不良反应（如白细胞、血小板降低）。有研究显示，Ⅲ期试验中≥3级中性粒细胞减少发生率约为28%\u003Csup>\u003Ca href=\"#ref2\">[2]\u003C/a>\u003C/sup>。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>泼尼松\u003C/strong>：长期使用可能导致血糖升高、骨质疏松等，建议定期监测血糖和骨密度。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"expert-info-box\">\n      😊 \u003Cstrong>对策建议：\u003C/strong>按照医嘱定期查血，出现持续发热、严重虚弱、呼吸急促、皮疹等立即报告医生处理。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 7. 特殊人群及用药调整 -->\n  \u003Ch2 class=\"expert-subtitle expert-bg-special\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    07 特殊人群的用药调整与关注点\n  \u003C/h2>\n  \u003Cdiv class=\"expert-subtitle-bg subtle-bg\">\u003C/div>\n  \u003Cdiv class=\"expert-section\">\n    \u003Cul class=\"expert-ul-list\">\n      \u003Cli>\n        \u003Cstrong>老年人\u003C/strong>：肝肾代谢功能减弱，建议根据实际情况调整剂量。\u003Cbr>\n        \u003Cspan class=\"expert-tip\">如来那度胺、环磷酰胺等应先查功能指标再用药。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>肝肾功能障碍患者\u003C/strong>：许多化疗药物由肝、肾代谢，严重障碍需慎用或调整剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>生育或计划妊娠者\u003C/strong>：来那度胺、环磷酰胺具致畸作用，男女双方用药期间及停药后几个月均须避孕。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>糖尿病、高血压合并患者\u003C/strong>：糖皮质激素（如泼尼松）可影响血糖和血压，应调整降糖、降压药，应加强血糖血压监测。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"expert-case-box\">\n      \u003Cstrong>真实用药案例：\u003C/strong>\n      \u003Cbr>\n      一位老年女性患者，在使用来那度胺联合治疗前因肾功能略差予以减半剂量，监测后未出现严重不良反应，治疗顺利完成。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 8. 储存条件与有效期要点 -->\n  \u003Ch2 class=\"expert-subtitle expert-bg-storage\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    08 药品储存与有效期细节\n  \u003C/h2>\n  \u003Cdiv class=\"expert-subtitle-bg subtle-bg\">\u003C/div>\n  \u003Cdiv class=\"expert-section\">\n    \u003Cul class=\"expert-ul-list\">\n      \u003Cli>\n        \u003Cstrong>利妥昔单抗、多柔比星等注射液\u003C/strong>：需冷藏于2-8℃，勿冷冻、避光，稀释后应限时用完。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>口服药品（来那度胺、泼尼松）\u003C/strong>：常温避光保存，避免潮湿，瓶盖务必拧紧存放儿童触及不到的地方。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>过期药品\u003C/strong>：切勿继续服用，建议投向有害垃圾回收点，不可随意丢弃。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"expert-info-box\">\n      \u003Cstrong>储存建议：\u003C/strong>随时检查外观、瓶签信息，药片变色、发霉，液体变混浊时立即废弃。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 9. 漏服&过量用药处理方法 -->\n  \u003Ch2 class=\"expert-subtitle expert-bg-error\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    09 漏服与过量用药的处理方法\n  \u003C/h2>\n  \u003Cdiv class=\"expert-subtitle-bg subtle-bg\">\u003C/div>\n  \u003Cdiv class=\"expert-section\">\n    \u003Cul class=\"expert-ul-list\">\n      \u003Cli>\n        \u003Cstrong>口服药物\u003C/strong>：如发现漏服，记起时立即补服。若临近期下一次服药，跳过漏服这次，不可一次服用双倍剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>化疗药、注射剂\u003C/strong>：漏服不得自行补药，须交由医师评估安排调整。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>过量用药\u003C/strong>：出现明显不适（如严重恶心、呕吐、昏迷等）应尽快就诊，保留药品包装交医生判断药品用量。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"expert-info-box\">\n      \u003Cstrong>正确做法：\u003C/strong>用药期间建立服药计划提醒，避免漏服与重复服药。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 10. 总结与安全提醒 -->\n  \u003Ch2 class=\"expert-subtitle expert-bg-summary\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    10 关键总结：安全用药让疗效最大化\n  \u003C/h2>\n  \u003Cdiv class=\"expert-subtitle-bg subtle-bg\">\u003C/div>\n  \u003Cdiv class=\"expert-section\">\n    \u003Cp>\n      针对弥漫大B细胞淋巴瘤的常用药物，每一步从正确选药、服药，到规避不良反应，都有标准答案。\u003Cbr>\n      \u003Cspan class=\"expert-highlight\">最关键的两点：\u003C/span>\n      \u003C/p>\u003Col>\n        \u003Cli>所有药物都需在专业医生指导下使用，尤其注射类药品不可自行操作。\u003C/li>\n        \u003Cli>遇严重的不良反应、漏服、过量，用药问题不可隐瞒，一定要马上就医，不拖延。\u003C/li>\n      \u003C/ol>\n      合理用药、安全用药，是获得理想效果、减少风险的最好保障。遇到用药疑问，及时问医生或药师，是每位患者的明智选择。\n    \u003Cp>\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 11. 主要参考文献 -->\n  \u003Ch2 class=\"expert-subtitle expert-bg-ref\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    参考文献\n  \u003C/h2>\n  \u003Cdiv class=\"expert-subtitle-bg subtle-bg\">\u003C/div>\n  \u003Cdiv class=\"expert-section\">\n    \u003Col class=\"expert-ref-list\">\n      \u003Cli id=\"ref1\">\n        Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., ... & Salles, G. (2002). CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. \u003Cem>New England Journal of Medicine\u003C/em>, 346(4), 235-242.\n      \u003C/li>\n      \u003Cli id=\"ref2\">\n        Wiernik, P. H., Lossos, I. S., Justice, R. E., Vose, J. M., Tuscano, J. M., Cole, C. E., ... & Zeldis, J. B. (2013). Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin’s lymphoma. \u003Cem>Journal of Clinical Oncology\u003C/em>, 31(29), 3552-3558.\n      \u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.expert-content-wrapper {\n  margin: 0 auto;\n  padding: 28px 18px 40px 18px;\n  max-width: 900px;\n  background: #f7f8fa;\n  border-radius: 12px;\n  font-family: \"Helvetica Neue\", Arial, \"PingFang SC\", \"Microsoft YaHei\", sans-serif;\n  color: #222;\n}\n.expert-title {\n  color: #23408a;\n  background: linear-gradient(90deg, #e6eefa 40%, #ffffff 100%);\n  border-radius: 7px 7px 0 0;\n  font-size: 2.4em;\n  margin-bottom: 18px;\n  padding: 24px 18px 10px 18px;\n  font-weight: bold;\n  letter-spacing: 0.06em;\n}\n.expert-intro {\n  color: #456;\n  font-size: 1.15em;\n  margin-bottom: 38px;\n  padding: 12px 16px;\n  line-height: 1.7;\n  background: #f2f7f3;\n  border-left: 4px solid #86b0ab;\n  border-radius: 0 5px 5px 0;\n}\n.subtle-bg {\n  display: none;\n} \n.expert-section {\n  background: #fff;\n  border-radius: 7px;\n  box-shadow: 0 2px 4px 0 rgba(34,64,138,0.05);\n  padding: 26px 22px 20px 22px;\n  margin-bottom: 34px;\n  margin-top: 0;\n  min-height: 54px;\n}\n.expert-ul-list {\n  margin: 0 0 18px 0;\n  padding-left: 18px;\n  font-size: 1.11em;\n  line-height: 1.95;\n}\n.expert-ul-list li {\n  margin-bottom: 12px;\n  position: relative;\n  padding-left: 5px;\n}\n.expert-tip {\n  color: #b08728;\n  font-size: 0.98em;\n  margin-left: 7px;\n  font-style: italic;\n}\n.expert-highlight {\n  color: #186fa4;\n  font-weight: 600;\n}\n.expert-em {\n  color: #ac2121;\n  font-weight: 600;\n  font-style: italic;\n}\n.expert-info-box {\n  background: #f8f4e6;\n  border-left: 4px solid #b08728;\n  border-radius: 0 4px 4px 0;\n  color: #735917;\n  margin-top: 10px;\n  margin-bottom: 6px;\n  padding: 10px 14px 10px 12px;\n  font-size: 1em;\n}\n.expert-case-box {\n  background: #e8f3fe;\n  border-left: 4px solid #317ab6;\n  border-radius: 0 4px 4px 0;\n  color: #235070;\n  margin-top: 8px;\n  margin-bottom: 3px;\n  padding: 9px 12px 9px 10px;\n  font-size: 0.99em;\n}\n.expert-subtitle {\n  font-size: 1.52em;\n  font-weight: 700;\n  color: #1c4966;\n  padding: 28px 8px 12px 10px;\n  margin: 0 0 -9px 0;\n  letter-spacing: 0.05em;\n  position: relative;\n}\n.expert-subtitle-bg {\n  background: none !important;\n  height: 0;\n}\n.expert-bg-mechanism {\n  background: linear-gradient(90deg,#e7f1ec 60%,#ffffff 100%);\n}\n.expert-bg-usage {\n  background: linear-gradient(90deg,#f7efe2 60%,#ffffff 100%);\n}\n.expert-bg-form {\n  background: linear-gradient(90deg,#e9e3f7 60%,#ffffff 100%);\n}\n.expert-bg-interaction {\n  background: linear-gradient(90deg,#f2e7f2 60%,#ffffff 100%);\n}\n.expert-bg-indication {\n  background: linear-gradient(90deg,#eaf1ec 60%,#ffffff 100%);\n}\n.expert-bg-adverse {\n  background: linear-gradient(90deg,#faeee8 60%,#ffffff 100%);\n}\n.expert-bg-special {\n  background: linear-gradient(90deg,#e8f1fa 60%,#ffffff 100%);\n}\n.expert-bg-storage {\n  background: linear-gradient(90deg,#f6f4ea 60%,#ffffff 100%);\n}\n.expert-bg-error {\n  background: linear-gradient(90deg,#f7e8ec 60%,#ffffff 100%);\n}\n.expert-bg-summary {\n  background: linear-gradient(90deg,#edeff7 60%,#ffffff 100%);\n}\n.expert-bg-ref {\n  background: linear-gradient(90deg,#ededed 60%,#ffffff 100%);\n}\n.expert-ref-list {\n  margin: 0;\n  padding-left: 20px;\n  color: #7e7c7a;\n  font-size: 0.99em;\n  line-height: 1.7;\n}\na {\n  color: #337ab7;\n  text-decoration: none;\n}\na:hover {\n  text-decoration: underline;\n}\n@media (max-width: 640px) {\n  .expert-content-wrapper {\n    padding: 14px 2px 14px 2px;\n    max-width: 100%;\n  }\n  .expert-section {\n    padding: 16px 6px 14px 9px;\n  }\n  .expert-title, .expert-subtitle {\n    padding-left: 7px;\n    padding-right: 3px;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"expert-content-wrapper\">\n\n  \u003C!-- 标题区 -->\n  \u003Ch1 id=\"material_title\" class=\"expert-title\" ",499,"2025-07-23 10:09:11","弥漫大B细胞淋巴瘤, 利妥昔单抗, 药物安全用药, CHOP方案, 不良反应","本指南提供针对弥漫大B细胞淋巴瘤治疗的安全用药全解析，涵盖主要药物、用法、注意事项等，帮助患者安心用药，降低风险。","2025-08-02 13:06:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]